NCT05639465 Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
| NCT ID | NCT05639465 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Emotional Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2022-11-15 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2022-11-15 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Racial and ethnic minority children who live in socioeconomically disadvantaged communities are disproportionately impacted by pandemic and climate-induced disasters. Although effective interventions have been designed to treat mental health related symptoms in post-disaster settings, accessible, empirically supported prevention interventions are needed to prevent the onset of mental and behavioral health issues among these children. Building on our preliminary findings, the proposed study examines the efficacy and implementation of a COVID-19 adapted disaster focused prevention intervention, Journey of Hope-C19, in preventing behavioral health and interpersonal problems among racial and ethnic minority children who live in low-resource high poverty communities.
Eligibility Criteria
Inclusion Criteria: * child experienced the COVID-19 pandemic and an additional large-scale disaster * child score is 5 or above on the Strengths and Difficulties Questionnaire * child is in 3- 8th grade at enrollment * the parent or guardian must complete informed consent and child assent * child must speak English or Spanish. Exclusion Criteria: * child is currently receiving treatment for a diagnosed mental health condition * children who are not able to interact with other students in a group work format, regardless of IEP status
Contact & Investigator
Tara Leytham Powell, PhD
PRINCIPAL INVESTIGATOR
University of Illinois Urbana Champaign
Frequently Asked Questions
Who can join the NCT05639465 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 14 Years, studying Emotional Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05639465 currently recruiting?
Yes, NCT05639465 is actively recruiting participants. Contact the research team at tlpowell@illinois.edu for enrollment information.
Where is the NCT05639465 trial being conducted?
This trial is being conducted at Bradenton, United States, Panama City, United States, St. Petersburg, United States, West Palm Beach, United States and 5 additional locations.
Who is sponsoring the NCT05639465 clinical trial?
NCT05639465 is sponsored by University of Illinois at Urbana-Champaign. The principal investigator is Tara Leytham Powell, PhD at University of Illinois Urbana Champaign. The trial plans to enroll 800 participants.